CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
-20.32%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.3B
AUM Growth
+$1.3B
(-23%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
7.98%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
86
New
8
Increased
9
Reduced
24
Closed
9
Top Buys
Top Sells
| 1 |
Beam Therapeutics
BEAM
|
$23.5M |
| 2 |
Aclaris Therapeutics
ACRS
|
$13.1M |
| 3 |
Revolution Medicines
RVMD
|
$11.1M |
| 4 |
Cytokinetics
CYTK
|
$11M |
| 5 |
Zymeworks
ZYME
|
$9.83M |
Sector Composition
| 1 | Healthcare | 98.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORTX
76
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $183K | 0.01% |
256,649
| – | – |
|
77
X4 Pharmaceuticals
XFOR
$70M
| $182K | 0.01% |
103,980
| – | – |
|
|
OTLKW
78
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
| – | – |
-270,698
| Closed | -$32K |
|
|
79
Zymeworks
ZYME
$1.07B
| – | – |
-600,000
| Closed | -$9.83M |
|
80
uniQure
QURE
$954M
| – | – |
-50,000
| Closed | -$1.04M |
|
81
Merus
MRUS
$5.04B
| – | – |
-100,000
| Closed | -$3.18M |
|
|
CNTB
82
Connect Biopharma
CNTB
$111M
| – | – |
-200,000
| Closed | -$1.03M |
|
83
Celldex Therapeutics
CLDX
$1.57B
| – | – |
-100,000
| Closed | -$3.86M |
|
84
Aligos Therapeutics
ALGS
$75.1M
| – | – |
-521,257
| Closed | -$6.19M |
|
|
85
Aclaris Therapeutics
ACRS
$223M
| – | – |
-900,000
| Closed | -$13.1M |
|
|
SONX
86
DELISTED
Sonendo, Inc.
SONX
| – | – |
-149,200
| Closed | -$859K |
|